Remove BioTech Remove Health Information Remove Life Science Remove Telehealth
article thumbnail

Emerging trends in the European HealthTech M&A market 2023

Lloyd Price

Growth of the life sciences sector: The life sciences sector is expected to continue to grow in 2023, driven by the development of new drugs and therapies, as well as the increasing demand for personalized medicine. The overall outlook for the European HealthTech M&A market in 2023 is positive.

article thumbnail

Pharma IT and AI – 2024 Health IT Predictions

Healthcare IT Today

Health Economics Outcomes Research (HEOR) will become more common in decentralized clinical trials (DCTs). This year we saw the maturation of Claims and Health Information Exchanges, which enable a cost-effective and straightforward process for researchers to gain access to identified patients’ data.